Google Custom Search

HCV Found in Carotid Atherosclerosis Plaques of Chronic Hepatitis C Patients

SUMMARY: Hepatitis C virus (HCV) was detected in arterial plaques in the carotid arteries of chronic hepatitis C patients with heart disease, according to a study in the January 2010 Journal of Clinical Virology. While the implications of this novel finding are not yet clear, it is possible that HCV may have a direct influence on atherosclerosis.

By Liz Highleyman

Research indicates that chronic hepatitis C is associated with increased risk of cardiovascular disease in both HCV monoinfected and HIV/HCV coinfected people, even though HCV infection tends to lower blood lipid levels. Some evidence suggests HCV infection may promote accumulation of carotid artery plaques, or build-up of cholesterol and other substances on the walls of the arteries in the neck that supply the brain.

Maria Boddi from the University of Florence, Italy, and colleagues conducted a study to evaluate the presence of HCV genomic sequences and replicative intermediates in artery plaque tissues. The HCV genome is a positive-strand RNA that serves as the viral genetic "blueprint," while a replicative intermediate is a negative-strand RNA utilized in the copying process.

The researchers analyzed a cohort of chronic hepatitis C patients seen at the University Hospital in Florence who had chronic ischemic heart disease, in which the heart is deprived of oxygen due to atherosclerosis.

Results

Positive-strand HCV RNA was found in 7 carotid plaque tissue samples obtained from HCV antibody positive patients.
Positive-strand HCV RNA was not detected, however, in the 9 carotid plaque samples from HCV antibody negative patients.
3 patients had HCV RNA detectable in carotid plaque but not in blood serum.
Negative-strand HCV replicative intermediates were detected in 3 plaque samples.
Direct sequencing of HCV RNA from plaque and serum samples showed HCV genotypes 2 (5 cases) and 1 (2 cases).

"The novel finding of HCV RNA sequences in plaque tissue strongly suggests an active local infection," the study authors concluded. "This in turn makes it conceivable that the virus may exert local action in carotid atherosclerosis."

Clinica Medica Generale e Cardiologia, Department of Medical and Surgical Critical Care, University of Florence, Italy.

1/15/10

Reference
M Boddi, R Abbate, B Chellini, and others. Hepatitis C virus RNA localization in human carotid plaques. Journal of Clinical Virology 47(1): 72-75 (Abstract). January 2010.


 


 




 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FDA-approved Combination Therapies for Chronic HCV Infection
Pegasys + Copegus
PEG-Intron + Rebetol
Intron A + Rebetol
Roferon A + Ribavirin


Treatment Guidelines
Experimental Treatments

HCV Articles by Topic

Cirrhosis
Fibrosis
Hepatocellular Carcinoma
Liver Transplantation
Liver Biopsy

Steatosis
Anemia
Children / Infants / Women
Drug Abuse
Experimental Treatments
FAQs About Hepatitis C
Genotypes
Insulin Resistance / Diabetes
Sustained Viral Response (SVR)
Tests for HCV
Vaccines for HCV